OVER three quarters of Brits are familiar with CBD, whilst in France, just over one-third aware of it.
The French are also the most sceptical of CBD whilst their Swiss neighbours are the most engaged, European research has revealed.
The findings from New Frontier Data found French respondents are least likely to agree that CBD had valid medical uses – at 46% – nine points less than the rest of Europe.
Whilst they are also the most likely to believe that CBD should only be available with a doctor’s recommendation, at 49%, compared to 36% on the rest of the continent.
Meanwhile, in Switzerland and Austria more than half – 53% – are positive about CBD, compared to 42% of Europeans overall.
The October 2019 European CBD Survey polled 3,100 respondents from the continent about their attitudes and CBD use.
It found that most consumers are using CBD to treat, pain, at 40%, for relaxation, at 34%, and to reduce stress and anxiety levels at 31% and 26% respectively.
In relation to CBD usage the French were once again at the bottom with 7% compared to 16% of all Europeans.
There is also a marked difference in familiarity with cannabidiol – or CBD – in France at 36% compared to 78% in the United Kingdom and Ireland.
However, this French scepticism towards CBD, and all things cannabis, is currently under attack from two sides.
Earlier this year the Government approved the country’s first medical cannabis trial, and the French Parliament looks set to ease restrictions on the CBD wellness market.
